• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无血清条件下新型带有人工细胞黏附蛋白微载体上vero 细胞的生长和脊髓灰质炎病毒的生产。

Growth and poliovirus production of Vero cells on a novel microcarrier with artificial cell adhesive protein under serum-free conditions.

机构信息

Department of Microbiology, School of Medicine, Iwate Medical University, Morioka, Iwate, Japan.

出版信息

J Biosci Bioeng. 2011 May;111(5):600-4. doi: 10.1016/j.jbiosc.2010.12.018. Epub 2011 Jan 23.

DOI:10.1016/j.jbiosc.2010.12.018
PMID:21262586
Abstract

A microcarrier is used for the three-dimensional (3D) culture of adhesion-dependent mammalian cells. We developed a novel microcarrier by binding ProNectin F, an artificial cell adhesive protein synthesized by genetically engineered Escherichia coli to a polyacrylic superabsorbent polymer. The microcarrier is characterized by containing no animal-derived components. The serum-free culture of Vero cells for vaccine production using the microcarrier increased the number of Vero cells by approximately 30% compared with the existing dextran beads coated with porcine Type I collagen, which resulted in approximately a 30% to 40% increase in the infectivity titer of the Sabin 2 strain of poliovirus. These results suggested that the developed microcarrier should be unprecedented in permitting high-yield vaccine production by means of a serum-free culture.

摘要

微载体用于依附性哺乳动物细胞的三维(3D)培养。我们通过将人工细胞黏附蛋白 ProNectin F 与聚丙烯酸超吸收聚合物结合,开发出一种新型微载体。该微载体的特点是不含动物源性成分。使用该微载体进行无血清培养生产疫苗时,与现有的用猪 I 型胶原包被的葡聚糖珠相比,Vero 细胞的数量增加了约 30%,导致脊髓灰质炎病毒 Sabin 2 株的感染力滴度增加了约 30%至 40%。这些结果表明,通过无血清培养,开发的微载体应该能够前所未有地实现高产疫苗生产。

相似文献

1
Growth and poliovirus production of Vero cells on a novel microcarrier with artificial cell adhesive protein under serum-free conditions.无血清条件下新型带有人工细胞黏附蛋白微载体上vero 细胞的生长和脊髓灰质炎病毒的生产。
J Biosci Bioeng. 2011 May;111(5):600-4. doi: 10.1016/j.jbiosc.2010.12.018. Epub 2011 Jan 23.
2
Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.在无血清PER.C6(®)细胞培养平台上生产高滴度减毒脊髓灰质炎病毒株,以生成安全且价格合理的下一代灭活脊髓灰质炎疫苗。
Vaccine. 2015 Nov 27;33(48):6611-6. doi: 10.1016/j.vaccine.2015.10.091. Epub 2015 Nov 1.
3
High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.高免疫原性肠道病毒71型毒株及其利用无血清微载体Vero细胞培养的生产方法。
Vaccine. 2007 Jan 2;25(1):19-24. doi: 10.1016/j.vaccine.2006.06.083. Epub 2006 Aug 2.
4
A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.一种在完全无动物成分条件下于搅拌式生物反应器中培养的Vero细胞中增殖狂犬病病毒的微载体细胞培养工艺。
Vaccine. 2007 May 10;25(19):3879-89. doi: 10.1016/j.vaccine.2007.01.086. Epub 2007 Feb 5.
5
Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development.用于灭活肠道病毒71型疫苗研发的微载体细胞培养工艺优化
Vaccine. 2004 Sep 28;22(29-30):3858-64. doi: 10.1016/j.vaccine.2004.05.037.
6
Stationary and microcarrier cell culture processes for propagating Japanese encephalitis virus.用于繁殖日本脑炎病毒的固定化细胞培养和微载体细胞培养方法。
Biotechnol Prog. 2002 Jan-Feb;18(1):124-8. doi: 10.1021/bp010120q.
7
Suspension-Vero cell cultures as a platform for viral vaccine production.悬浮Vero细胞培养作为病毒疫苗生产的平台。
Vaccine. 2009 Oct 30;27(46):6464-7. doi: 10.1016/j.vaccine.2009.06.020. Epub 2009 Jun 24.
8
Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium.在搅拌罐生物反应器中使用无血清培养基提高用于黄热病毒生产的Vero活细胞密度。
Vaccine. 2015 Aug 20;33(35):4288-91. doi: 10.1016/j.vaccine.2015.04.050. Epub 2015 Apr 27.
9
Monkey kidney cell growth optimization and poliovirus propagation in microcarrier culture.微载体培养中猴肾细胞生长优化及脊髓灰质炎病毒增殖
Dev Biol Stand. 1981;47:41-53.
10
Production of yellow fever virus in microcarrier-based Vero cell cultures.在基于微载体的非洲绿猴肾细胞培养物中生产黄热病毒。
Vaccine. 2009 Oct 30;27(46):6420-3. doi: 10.1016/j.vaccine.2009.06.023. Epub 2009 Jun 24.

引用本文的文献

1
Production of a chimeric porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine using a lab-scale packed-bed bioreactor CelCradle.使用实验室规模的填充床生物反应器 CelCradle 生产嵌合猪繁殖与呼吸综合征病毒(PRRSV)-2 疫苗。
BMC Vet Res. 2023 Aug 2;19(1):105. doi: 10.1186/s12917-023-03659-4.
2
Vero cell upstream bioprocess development for the production of viral vectors and vaccines.用于生产病毒载体和疫苗的vero 细胞上游生物工艺开发。
Biotechnol Adv. 2020 Nov 15;44:107608. doi: 10.1016/j.biotechadv.2020.107608. Epub 2020 Aug 5.
3
Large-scale microcarrier culture of HEK293T cells and Vero cells in single-use bioreactors.
在一次性生物反应器中对HEK293T细胞和Vero细胞进行大规模微载体培养。
AMB Express. 2019 May 24;9(1):70. doi: 10.1186/s13568-019-0794-5.
4
The use of Toxoplasma gondii tachyzoites produced in HeLa cells adhered to Cytodex 1 microcarriers as antigen in serological assays: an application of microcarrier technology.在血清学检测中,使用在HeLa细胞中产生并附着于Cytodex 1微载体上的刚地弓形虫速殖子作为抗原:微载体技术的一种应用
Cytotechnology. 2019 Feb;71(1):91-105. doi: 10.1007/s10616-018-0269-6. Epub 2019 Jan 3.